Lorcaserin Extended-Release Tablets and Polatuzumab Vedotin-piiq
Determining the interaction of Lorcaserin Extended-Release Tablets and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Polio vaccine, inactivated
- Lorcaserin Extended-Release Tablets-Poliovirus Vaccine (Inactivated)
- Lorcaserin Extended-Release Tablets-Poliovirus vaccine, inactivated Injection
- Lorcaserin Extended-Release Tablets-Polivy
- Lorcaserin Extended-Release Tablets-Polmon
- Lorcaserin Extended-Release Tablets-Polocaine
- Polatuzumab Vedotin-piiq-Lorcaserin Hydrochloride
- Polatuzumab Vedotin-piiq-Lorcaserin Tablets
- Polatuzumab Vedotin-piiq-Lorcet
- Polatuzumab Vedotin-piiq-Lorcet Plus
- Polatuzumab Vedotin-piiq-Lorcet Tablets
- Polatuzumab Vedotin-piiq-Lorlatinib